| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b182d066bea96fba5decfe5379fbc8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a37e0decea86ea50b285e704d33caf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fcb967aefce8411a27509fa6e9fd6ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87734d3b3ddff528d00ea42d425309e9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 |
| filingDate |
2012-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdb383bcbcfd876ecb2f4d7d16ce9f41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59fe547296a3c1d3921b0d9c40dc1e3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_631ca93ab3609dfe41cf88022f3e8aad |
| publicationDate |
2014-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8796203-B2 |
| titleOfInvention |
Use of tight junction antagonists to treat inflammatory bowel disease |
| abstract |
The present invention provides materials and methods for the treatment of inflammatory bowel disease (e.g., Crohn's disease and ulcerative colitis). Materials of the invention may include compositions comprising one or more tight junction antagonists and optionally one or more therapeutic agents. Methods of the invention may comprise treating a subject in need thereof with a composition comprising one or more tight junction antagonists and, optionally one or more therapeutic agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3881830-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11608359-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014128321-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11149063-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11058902-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11278587-B2 |
| priorityDate |
2006-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |